Analysis of Discordance between Genotypic and Phenotypic Assays for Rifampicin-Resistant <i>Mycobacterium tuberculosis</i> Isolated from Healthcare Facilities in Mthatha

The study sought to determine the rate of discordant results between genotypic and phenotypic tests for the diagnosis of drug-resistant tuberculosis (DR-TB). Sputum samples and cultured isolates from suspected DR-TB patients were, respectively, analyzed for <i>Mycobacterium tuberculosis</i&...

Full description

Bibliographic Details
Main Authors: Carine Bokop, Lindiwe M. Faye, Teke Apalata
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/12/7/909
_version_ 1797587889494687744
author Carine Bokop
Lindiwe M. Faye
Teke Apalata
author_facet Carine Bokop
Lindiwe M. Faye
Teke Apalata
author_sort Carine Bokop
collection DOAJ
description The study sought to determine the rate of discordant results between genotypic and phenotypic tests for the diagnosis of drug-resistant tuberculosis (DR-TB). Sputum samples and cultured isolates from suspected DR-TB patients were, respectively, analyzed for <i>Mycobacterium tuberculosis</i> by Xpert<sup>®</sup> MTB/RIF (Cepheid, Sunnyvale, CA, USA) and line probe assays (LPA) (Hain, Nehren, Germany). Discrepant rifampicin (RMP)-resistant results were confirmed using BACTEC MGIT960 (BD, New York, NY, USA). Of the 224 RMP-resistant results obtained by Xpert MTB/RIF, 5.4% were susceptible to RMP by LPA. MGIT960 showed a 75% agreement with LPA. The discrepancy was attributed to either heteroresistance or DNA contamination during LPA testing in 58.3% of cases. In 25% of the samples showing agreement in RMP resistance between Xpert MTB/RIF and MGIT960, the discrepancy was attributed to laboratory errors causing false RMP susceptible results with LPA. In 16.7% of the cases, the discrepancy was attributed to false RMP susceptible results with Xpert MTB/RIF. Out of the 224 isolates, susceptibility to isoniazid (INH) by LPA was performed in 73.7% RMP-resistant isolates, of which, 80.6% were resistant. All RMP-resistant isolates by Xpert MTB/RIF were confirmed in 98.5% by LPA if TB isolates were resistant to INH, but were only confirmed in 81.3% if TB isolates were susceptible to INH (<i>p</i> < 0.001). In conclusion, laboratory errors should be considered when investigating discordant results.
first_indexed 2024-03-11T00:45:13Z
format Article
id doaj.art-b7ea2bb646a04390bed6ff7606b03610
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-03-11T00:45:13Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-b7ea2bb646a04390bed6ff7606b036102023-11-18T20:50:45ZengMDPI AGPathogens2076-08172023-07-0112790910.3390/pathogens12070909Analysis of Discordance between Genotypic and Phenotypic Assays for Rifampicin-Resistant <i>Mycobacterium tuberculosis</i> Isolated from Healthcare Facilities in MthathaCarine Bokop0Lindiwe M. Faye1Teke Apalata2Division of Medical Microbiology, Department of Laboratory Medicine and Pathology, Faculty of Health Sciences, Walter Sisulu University, Mthatha 5099, Eastern Cape, South AfricaDepartment of Laboratory Medicine and Pathology, Faculty of Health Sciences and National Health Laboratory Services (NHLS), Walter Sisulu University, Mthatha 5099, Eastern Cape, South AfricaDepartment of Laboratory Medicine and Pathology, Faculty of Health Sciences and National Health Laboratory Services (NHLS), Walter Sisulu University, Mthatha 5099, Eastern Cape, South AfricaThe study sought to determine the rate of discordant results between genotypic and phenotypic tests for the diagnosis of drug-resistant tuberculosis (DR-TB). Sputum samples and cultured isolates from suspected DR-TB patients were, respectively, analyzed for <i>Mycobacterium tuberculosis</i> by Xpert<sup>®</sup> MTB/RIF (Cepheid, Sunnyvale, CA, USA) and line probe assays (LPA) (Hain, Nehren, Germany). Discrepant rifampicin (RMP)-resistant results were confirmed using BACTEC MGIT960 (BD, New York, NY, USA). Of the 224 RMP-resistant results obtained by Xpert MTB/RIF, 5.4% were susceptible to RMP by LPA. MGIT960 showed a 75% agreement with LPA. The discrepancy was attributed to either heteroresistance or DNA contamination during LPA testing in 58.3% of cases. In 25% of the samples showing agreement in RMP resistance between Xpert MTB/RIF and MGIT960, the discrepancy was attributed to laboratory errors causing false RMP susceptible results with LPA. In 16.7% of the cases, the discrepancy was attributed to false RMP susceptible results with Xpert MTB/RIF. Out of the 224 isolates, susceptibility to isoniazid (INH) by LPA was performed in 73.7% RMP-resistant isolates, of which, 80.6% were resistant. All RMP-resistant isolates by Xpert MTB/RIF were confirmed in 98.5% by LPA if TB isolates were resistant to INH, but were only confirmed in 81.3% if TB isolates were susceptible to INH (<i>p</i> < 0.001). In conclusion, laboratory errors should be considered when investigating discordant results.https://www.mdpi.com/2076-0817/12/7/909Xpert MTB/RIFline probe assayMGIT 960 system<i>Mycobacterium tuberculosis</i>discrepant results
spellingShingle Carine Bokop
Lindiwe M. Faye
Teke Apalata
Analysis of Discordance between Genotypic and Phenotypic Assays for Rifampicin-Resistant <i>Mycobacterium tuberculosis</i> Isolated from Healthcare Facilities in Mthatha
Pathogens
Xpert MTB/RIF
line probe assay
MGIT 960 system
<i>Mycobacterium tuberculosis</i>
discrepant results
title Analysis of Discordance between Genotypic and Phenotypic Assays for Rifampicin-Resistant <i>Mycobacterium tuberculosis</i> Isolated from Healthcare Facilities in Mthatha
title_full Analysis of Discordance between Genotypic and Phenotypic Assays for Rifampicin-Resistant <i>Mycobacterium tuberculosis</i> Isolated from Healthcare Facilities in Mthatha
title_fullStr Analysis of Discordance between Genotypic and Phenotypic Assays for Rifampicin-Resistant <i>Mycobacterium tuberculosis</i> Isolated from Healthcare Facilities in Mthatha
title_full_unstemmed Analysis of Discordance between Genotypic and Phenotypic Assays for Rifampicin-Resistant <i>Mycobacterium tuberculosis</i> Isolated from Healthcare Facilities in Mthatha
title_short Analysis of Discordance between Genotypic and Phenotypic Assays for Rifampicin-Resistant <i>Mycobacterium tuberculosis</i> Isolated from Healthcare Facilities in Mthatha
title_sort analysis of discordance between genotypic and phenotypic assays for rifampicin resistant i mycobacterium tuberculosis i isolated from healthcare facilities in mthatha
topic Xpert MTB/RIF
line probe assay
MGIT 960 system
<i>Mycobacterium tuberculosis</i>
discrepant results
url https://www.mdpi.com/2076-0817/12/7/909
work_keys_str_mv AT carinebokop analysisofdiscordancebetweengenotypicandphenotypicassaysforrifampicinresistantimycobacteriumtuberculosisiisolatedfromhealthcarefacilitiesinmthatha
AT lindiwemfaye analysisofdiscordancebetweengenotypicandphenotypicassaysforrifampicinresistantimycobacteriumtuberculosisiisolatedfromhealthcarefacilitiesinmthatha
AT tekeapalata analysisofdiscordancebetweengenotypicandphenotypicassaysforrifampicinresistantimycobacteriumtuberculosisiisolatedfromhealthcarefacilitiesinmthatha